PCM
AH

Prelude Capital Management’s Accretive Health AH Stock Holding History

Prelude Capital Management’s Portfolio AH Stock Details AH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-32,400
Closed -$259K – 2461
2014
Q1 		$259K Buy
32,400
+13,000
+67% +$115K 0.03% 640
2013
Q4 		$178K Buy
+19,400
New +$167K 0.03% 649

Other funds holding AH

JRP
Jasper Ridge Partners Menlo Park, California $4.69B AUM 31.34% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
RMC
Regis Management Company Menlo Park, California $331M AUM 14.13% 1-Year Est. Return
BCM
Breithorn Capital Management New York $141M AUM 41.82% 1-Year Est. Return
ECM
EII Capital Management New York $774K AUM 22.41% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
MIM
Merion Investment Management Bay Harbor Islands, Florida $1.26M AUM 28.57% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
SCM
Stonebridge Capital Management Los Angeles, California $208M AUM

Prelude Capital Management's AH Position: Q2 2014 in Review

Prelude Capital Management sold out of Accretive Health (AH) in Q2 2014, closing a stake of 32,400 shares — an estimated $259K sold.

Prelude Capital Management first reported a position in AH in Q4 2013 and held it in 2 quarters. The position peaked at $259K in Q1 2014. 12 funds tracked by Wall St. Rank hold AH as of Q2 2014.

  • Prelude Capital Management reported no remaining Accretive Health position as of Q2 2014 after selling out during the quarter.
  • Prelude Capital Management sold 32,400 Accretive Health shares in Q2 2014, an estimated $259K.
  • Prelude Capital Management first reported a position in Accretive Health in Q4 2013 and held it in 2 quarters.
  • Prelude Capital Management's Accretive Health position peaked at $259K in Q1 2014.
  • 12 funds tracked by Wall St. Rank held Accretive Health as of Q2 2014.

Based on Prelude Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.